Thor Medical ASA
NANOV | OL
Overview
Corporate Details
- ISIN(s):
- NO0010597883 (+1 more)
- LEI:
- 5967007LIEEXZXG6DK30
- Country:
- Norway
- Address:
- Drammensveien 167, 0277 Oslo
- Website:
- https://www.thormedical.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
From rock to cancer drugs - Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The production process is based on a novel technology developed by Thor Medical that combines high efficiency and competitive cost structure with best in class environmental friendliness. All chemicals and radioactive materials are reprocessed and reused; therefore, the process produces very little waste. The process extracts only the radioactivity naturally occurring in thorium and therefore it requires no irradiation in nuclear reactors or high-cost accelerators. Since the source is thorium which decays with a half-life of 14 billion years we can produce continuously and provide a reliable supply of the sought-after alpha-particle emitters.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-18 23:46 |
Regulatory News Service
Thor Medical ASA: Key information relating to potential subsequent offering - A…
|
Norwegian | 63.0 KB | |
| 2025-06-18 23:46 |
Regulatory News Service
Thor Medical ASA: Key information relating to potential subsequent offering
|
Norwegian | 11.4 KB | |
| 2025-06-18 23:41 |
Major Shareholding Notification
Thor Medical ASA: Primary insider transaction and disclosure of large sharehold…
|
Norwegian | 129.3 KB | |
| 2025-06-18 23:41 |
Major Shareholding Notification
Thor Medical ASA: Primary insider transaction and disclosure of large sharehold…
|
Norwegian | 53.9 KB | |
| 2025-06-18 23:41 |
Major Shareholding Notification
Thor Medical ASA: Primary insider transaction and disclosure of large sharehold…
|
Norwegian | 4.5 KB | |
| 2025-06-18 23:32 |
Inside Information Statement
Thor Medical ASA: Private placement and retail offering through PrimaryBid succ…
|
Norwegian | 67.7 KB | |
| 2025-06-18 23:32 |
Inside Information Statement
Thor Medical ASA: Private placement and retail offering through PrimaryBid succ…
|
Norwegian | 16.1 KB | |
| 2025-06-18 16:30 |
Regulatory News Service
Thor Medical ASA - Contemplated private placement and retail offering through P…
|
English | 79.1 KB | |
| 2025-06-18 16:30 |
Inside Information Statement
Thor Medical ASA - Contemplated private placement and retail offering through P…
|
English | 22.1 KB | |
| 2025-06-16 07:30 |
Regulatory News Service
Thor Medical signs strategic sales agreement for Thorium-228 with global leader…
|
English | 54.3 KB | |
| 2025-06-16 07:30 |
Regulatory News Service
Thor Medical signs strategic sales agreement for Thorium-228 with global leader…
|
English | 5.4 KB | |
| 2023-03-23 00:00 |
Annual Report
|
English | 6.5 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M | |
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN |